Body composition and survival in the early clinical trials setting von Veasey Rodrigues, H, Baracos, V.E, Wheler, J.J, Parsons, H.A, Hong, D.S, Naing, A, Fu, S, Falchoock, G, Tsimberidou, A.M, Piha-Paul, S, Chisholm, G, Kurzrock, R

Volltext

Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs von Naing, A., Veasey-Rodrigues, H., Hong, D.S., Fu, S., Falchook, G.S., Wheler, J.J., Tsimberidou, A.M., Wen, S., Fessahaye, S.N., Golden, E.C., Aaron, J., Ewer, M.S., Kurzrock, R.

Volltext

The role of the electrocardiogram (ECG) in phase I drug development in patients with cancer: The University of Texas M. D. Anderson Cancer Center experience with 8,966 ECGs von Veasey Rodrigues, H., Naing, A., Hong, D. S., Falchook, G. S., Fu, S., Wheler, J. J., Tsimberidou, A. M., Moulder, S. L., Janku, F., Wen, S., Fessahaye, S. N., Golden, E. C., Westerhold, D. I., Ewer, M., Kurzrock, R.

Volltext

Electrocardiograms (ECGs) in phase I anticancer drug development: the MD Anderson Cancer Center experience with 8518 ECGs von Naing, A, Veasey-Rodrigues, H, Hong, D S, Fu, S, Falchook, G S, Wheler, J J, Tsimberidou, A M, Wen, S, Fessahaye, S N, Golden, E C, Aaron, J, Ewer, M S, Kurzrock, R

Volltext